See below for a list of organizations offering professional trainings.
Horizons is proud to present its first series of classes for professionals seeking to learn about psychedelic therapy. These classes offer mental health and medical professionals detailed, technical information about psychedelic therapy and direct access to experts and practitioners. Classes will held at the historic Down Town Association in the Financial District, NYC. American Psychological Association Continuing Education (CE) credits are also available. See here for more details.
The Psychedelic Education and Continuing Care Program offers trainings and workshops on Integrative Harm Reduction Psychotherapy (IHRP) and other complementary techniques, nationally, internationally and at our home in New York City. Our training sessions are collaborative, making use of group discussion, interactive skill-building components and case studies to foster a deeper understanding of IHRP and promote its practice. We tailor the content of training sessions and consultations to meet your specific requirements. Affiliated Psychedelic Support Providers: Ingmar Gorman, PhD and Elizabeth Neilson, PhD
The Psychedelic-Assisted Therapies and Research Certificate serves a growing need for the training of skilled therapist researchers who will ideally seek advanced training for future FDA-approved psychedelic-assisted and entactogen-assisted psychotherapy research. Enrollees are professionals in specific mental health and medical professions, as well as eligible ordained or commissioned clergy and chaplains.
MAPS MDMA Therapy Training Program trains therapists for administering MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder (PTSD). Currently the program is only available for therapists working on clinical trials. In preparation for anticipated FDA approval, an application to apply for the program will be open in early 2019.
The Ketamine Training Center provides training to medical professionals, therapists, clergy and hospice providers who desire to use Ketamine Assisted Psychotherapy (KAP) in a collaborative model that joins a prescribing physician with a therapeutic provider or a palliative caregiver.